http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03101668-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef2a6d661df17e57ad3155c24188735
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
filingDate 1989-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a2fccbf9915adbcd7acbdbc5b023db7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d78c7b434d82c343f9ba945d7e5c28f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31dbea8a8250c13e10ece4c0130a10bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_443f792dead4f02fce768dc843777ba3
publicationDate 1991-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03101668-A
titleOfInvention Production of tazanolast
abstract PURPOSE: To industrially advantageously obtain the title compound useful as an antiallergic agent having a purity sufficiently permissible as the raw material for medicine by reacting (A) 3-(1H-tetrazol-5-yl)aniline with (B) dibutyl oxalate in the presence of an acid. n CONSTITUTION: (A) 3-(1H-Tetrazol-5-yl)aniline is reacted with (B) dibutyl oxalate in the presence of (C) an acid, preferably hydrochloric acid, sulfuric acid or mixture thereof or one or more kinds of organic acids selected from oxalic acid, malonic acid, pyruvic acid and oxaloacetic acid, preferably at an amount of the ingredient B 5-10 times the ingredient A and an amount of the ingredient C 0.05-1.0 times, especially 0.3-0.4 times by mole based on the ingredient A at 80-100°C for 12-20hr and then the reaction product is purified, preferably by absorbing agent, especially an active alumina to provide butyl 3'-(1H- tetrazol-5-yl)oxanylate (tazanolast) with a high purity, high yield and good reproducibility. n COPYRIGHT: (C)1991,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007287879-A
priorityDate 1989-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9989226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410760501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410112156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408568853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414858461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235184569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID100643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226504653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451818717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67934870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414879602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226614069

Total number of triples: 41.